Akèy › Kansè fwa › Texas › Houston
Etid klinik pou Kansè fwa nan Houston, TX
14 etid pou Kansè fwa ap chèche patisipan nan sit nan ak bò kote Houston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
National Liver Cancer Screening Trial
Ap rekriteFaz 4
- Baylor College of Medicine, Houston
CREO - Microwave Ablation Feasibility Study
Ap rekrite
- Memorial Hermann-Texas Medical Center, Houston
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Ap rekriteFaz 1
- UT MD Anderson, Houston
Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
Ap rekriteFaz 1
- Texas Children's Hospital, Houston
Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- MD Anderson Cancer Center, Houston
A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
Ap rekriteFaz 1
- MD Anderson Cancer Center, Houston
- NEXT Houston, Houston
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
Ap rekriteFaz 1
- Clinical Trial Site, Houston
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Ap rekrite
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Ap rekriteFaz 1/2
- MD Anderson Cancer Center, Houston
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
Ap rekriteFaz 1/2
- MD Anderson Cancer Center, Houston
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Ap rekriteEtid obsèvasyon
- Md Anderson Cancer Center, Houston
Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma
Ap rekriteFaz 2
- Baylor College of Medicine, Houston
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Houston
Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria
Ap rekriteFaz 4
- Houston Methodist Research Institute, Houston
Etid Kansè fwa nan lòt vil
- Los Angeles, CA11 etid
- Cleveland, OH11 etid
- Dallas, TX10 etid
- Boston, MA9 etid
- Chicago, IL8 etid
- St. Louis, MO8 etid
- Durham, NC7 etid
- Philadelphia, PA7 etid
- Washington, DC6 etid
- San Francisco, CA6 etid
- Orange, CA6 etid
- New York City, NY6 etid
Lòt etid nan Houston
- Kansè Poumon ki pa ti selil145 etid
- Kansè nan tete126 etid
- Kansè (tout kalite)121 etid
- Kansè Metastatik104 etid
- Kansè kolorektal102 etid
- Kansè ovè89 etid
- Leksemi mieloïd egi85 etid
- Kansè poumon78 etid
- Kansè pwostat76 etid
- Kansè Endomèt68 etid
- Kansè pankreyas61 etid
- Melanom59 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.